Aya El Helali, Vice President at Hong Kong Neuro-Oncology Society and Chair of The University of Hong Kong and Hong Kong Sanatorium Hospital Molecular Tumor Board, shared a post on LinkedIn:
“Thank you for joining us this morning at our session on Reporting Clinical Trials in the era of Precision Oncology at ESMO TAT Asia 2025 (ESMO – European Society for Medical Oncology) with a stellar panel of experts Annie Wong, Darren Wan-Teck Lim, and Herbert Loong.
Stay tuned for more updates and highlights from ESMO TAT Asia 2025!”
More posts featuring Aya El Helali.